- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.28 Å
- Oligo State
- monomer
- Ligands
- 1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x QR8: (3~{R},4~{S},5~{R},6~{S},7~{S},9~{S},11~{R},12~{S},13~{R},14~{R})-3,5,7,9,11,13,14-heptamethyl-4,6,12-tris(oxidanyl)-1-oxacyclotetradecane-2,10-dione(Non-covalent)
- 49 x FMT: FORMIC ACID(Non-functional Binders)
FMT.3: 3 residues within 4Å:- Chain A: R.105, H.355, C.356
Ligand excluded by PLIPFMT.4: 4 residues within 4Å:- Chain A: R.35, R.326, D.327, E.328
Ligand excluded by PLIPFMT.5: 3 residues within 4Å:- Chain A: R.57, S.59, S.307
Ligand excluded by PLIPFMT.6: 3 residues within 4Å:- Chain A: G.139, S.140, W.407
Ligand excluded by PLIPFMT.7: 7 residues within 4Å:- Chain A: V.145, V.150, R.172, V.250, K.392, L.400, E.401
Ligand excluded by PLIPFMT.8: 4 residues within 4Å:- Chain A: Y.47, R.82, P.85, A.186
Ligand excluded by PLIPFMT.9: 4 residues within 4Å:- Chain A: S.71, A.73, A.74, D.97
Ligand excluded by PLIPFMT.10: 3 residues within 4Å:- Chain A: R.123, S.126, L.127
Ligand excluded by PLIPFMT.11: 3 residues within 4Å:- Chain A: R.168, D.169, R.172
Ligand excluded by PLIPFMT.12: 3 residues within 4Å:- Chain A: Q.194, M.197, V.198
Ligand excluded by PLIPFMT.13: 2 residues within 4Å:- Chain A: K.110, T.113
Ligand excluded by PLIPFMT.14: 2 residues within 4Å:- Chain A: P.164, Q.206
Ligand excluded by PLIPFMT.15: 6 residues within 4Å:- Chain A: E.159, L.160, E.213, D.214, L.215
- Ligands: FMT.16
Ligand excluded by PLIPFMT.16: 3 residues within 4Å:- Chain A: E.159, E.213
- Ligands: FMT.15
Ligand excluded by PLIPFMT.17: 2 residues within 4Å:- Chain A: R.57, T.308
Ligand excluded by PLIPFMT.18: 4 residues within 4Å:- Chain A: R.266, L.337, D.338, F.339
Ligand excluded by PLIPFMT.19: 5 residues within 4Å:- Chain A: R.106, G.109, K.110
- Ligands: FMT.21, FMT.46
Ligand excluded by PLIPFMT.20: 1 residues within 4Å:- Chain A: A.16
Ligand excluded by PLIPFMT.21: 4 residues within 4Å:- Chain A: R.105, G.109, I.357
- Ligands: FMT.19
Ligand excluded by PLIPFMT.22: 4 residues within 4Å:- Chain A: P.18, P.22, S.292, A.293
Ligand excluded by PLIPFMT.23: 2 residues within 4Å:- Chain A: R.42, E.315
Ligand excluded by PLIPFMT.24: 3 residues within 4Å:- Chain A: F.349, H.355, R.363
Ligand excluded by PLIPFMT.25: 4 residues within 4Å:- Chain A: L.21, P.22, H.23, Q.393
Ligand excluded by PLIPFMT.26: 2 residues within 4Å:- Chain A: D.273, A.275
Ligand excluded by PLIPFMT.28: 1 residues within 4Å:- Chain A: R.343
Ligand excluded by PLIPFMT.29: 3 residues within 4Å:- Chain A: R.115, R.116, E.119
Ligand excluded by PLIPFMT.30: 2 residues within 4Å:- Chain A: P.8, P.10
Ligand excluded by PLIPFMT.31: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.32: 3 residues within 4Å:- Chain A: E.38, S.41, R.42
Ligand excluded by PLIPFMT.33: 1 residues within 4Å:- Ligands: FMT.34
Ligand excluded by PLIPFMT.34: 2 residues within 4Å:- Chain A: R.191
- Ligands: FMT.33
Ligand excluded by PLIPFMT.35: 5 residues within 4Å:- Chain A: A.11, D.12, E.49, G.50
- Ligands: FMT.36
Ligand excluded by PLIPFMT.36: 4 residues within 4Å:- Chain A: D.12, R.44, G.50
- Ligands: FMT.35
Ligand excluded by PLIPFMT.37: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.38: 4 residues within 4Å:- Chain A: D.67, S.68, P.98, A.353
Ligand excluded by PLIPFMT.39: 2 residues within 4Å:- Chain A: D.97, P.98
Ligand excluded by PLIPFMT.40: 1 residues within 4Å:- Chain A: R.376
Ligand excluded by PLIPFMT.41: 1 residues within 4Å:- Chain A: H.340
Ligand excluded by PLIPFMT.42: 6 residues within 4Å:- Chain A: V.204, A.205, R.208, A.220, T.223, D.224
Ligand excluded by PLIPFMT.43: 2 residues within 4Å:- Chain A: D.209, A.210
Ligand excluded by PLIPFMT.44: 2 residues within 4Å:- Chain A: E.268, V.271
Ligand excluded by PLIPFMT.45: 2 residues within 4Å:- Chain A: P.141, A.383
Ligand excluded by PLIPFMT.46: 2 residues within 4Å:- Chain A: K.110
- Ligands: FMT.19
Ligand excluded by PLIPFMT.47: 3 residues within 4Å:- Chain A: A.73, A.95, Q.96
Ligand excluded by PLIPFMT.48: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.49: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.50: 4 residues within 4Å:- Chain A: R.123, L.127, E.159
- Ligands: FMT.51
Ligand excluded by PLIPFMT.51: 2 residues within 4Å:- Chain A: R.123
- Ligands: FMT.50
Ligand excluded by PLIPFMT.52: 4 residues within 4Å:- Chain A: H.333, A.334, D.335, E.336
Ligand excluded by PLIP- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parisi, G. et al., Dissecting the Cytochrome P450 OleP Substrate Specificity: Evidence for a Preferential Substrate. Biomolecules (2020)
- Release Date
- 2020-10-21
- Peptides
- Cytochrome P-450: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.28 Å
- Oligo State
- monomer
- Ligands
- 1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x QR8: (3~{R},4~{S},5~{R},6~{S},7~{S},9~{S},11~{R},12~{S},13~{R},14~{R})-3,5,7,9,11,13,14-heptamethyl-4,6,12-tris(oxidanyl)-1-oxacyclotetradecane-2,10-dione(Non-covalent)
- 49 x FMT: FORMIC ACID(Non-functional Binders)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parisi, G. et al., Dissecting the Cytochrome P450 OleP Substrate Specificity: Evidence for a Preferential Substrate. Biomolecules (2020)
- Release Date
- 2020-10-21
- Peptides
- Cytochrome P-450: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
C